LG Chem (051910) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Jun, 2026Executive summary
Q1 2025 consolidated sales reached KRW 12,171 billion, with operating profit rebounding to KRW 447 billion (3.7% OPM) and net profit of KRW 260 billion, recovering from prior losses.
EBITDA improved to KRW 1,733 billion (14.2% margin), and gross profit margin rose to 16.8%.
Profitability improved quarter-over-quarter due to cost-cutting and increased sales of high-value-added products.
Strategic focus remains on operational optimization, business restructuring, and developing new growth drivers.
LG Energy Solution contributed 51.5% of sales, followed by petrochemicals (38.5%), advanced materials (5.8%), and life sciences (2.3%).
Financial highlights
Consolidated Q1 sales were KRW 12,171 billion, with operating profit of KRW 447 billion (OP margin 3.7%) and net profit of KRW 260 billion.
Gross profit margin was 16.8%; EBITDA reached KRW 1,733 billion.
Cash and equivalents at quarter-end were KRW 7.3 trillion.
Assets stood at KRW 95,100 billion, liabilities at KRW 47,000 billion, and capital at KRW 48,100 billion.
Debt ratio increased to 97.7% quarter-over-quarter.
Outlook and guidance
Expect continued volatility due to global economic slowdown, tariff changes, and demand reshoring.
Petrochemical profitability is expected to improve gradually in Q2 due to lower raw material prices and seasonal demand, but supply-demand balance recovery remains uncertain.
Advanced Materials faces demand uncertainty and potential shipment volume reduction in Q2 due to U.S. tariff policy changes.
Life Sciences will prioritize oncology drug development, maintain R&D investments, and continue global clinical trials.
Energy Solution anticipates continued demand uncertainty from external volatility and conservative OEM inventory strategies.
Latest events from LG Chem
- Q2 sales rose, but net income and guidance fell amid weak demand and higher costs.051910
Q2 202423 Jun 2026 - Q3 profit rose on Energy Solution gains, but outlook remains cautious amid market headwinds.051910
Q3 202423 Jun 2026 - Operating profit improved, but net income was negative amid persistent market headwinds.051910
Q2 202523 Jun 2026 - Q3 2025 profitability rebounded on cost cuts and one-time gains, but outlook stays cautious.051910
Q3 202523 Jun 2026 - Q1 2026 saw strong sales but a net loss, with batteries and petrochemicals as key drivers.051910
Q1 202622 Jun 2026 - Lower 2024 profits and weak demand drive restructuring, cost control, and cautious investment.051910
Q4 202428 May 2026 - Accelerating growth in sustainability, battery materials, and new drugs to drive future value.051910
Corporate presentation20 May 2026 - Four growth drivers are set to triple their revenue share by 2030 through strategic restructuring.051910
Corporate presentation20 May 2026 - Driving global sustainability and innovation with advanced materials and life sciences.051910
Corporate presentation20 May 2026